Sanofi
Search results
See our extensive range of human pharmaceutical and animal health products, see how our medicals products are improving patient lives human or animal.
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one.
At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heartbeat (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure ...
Boehringer Ingelheim is dedicated to providing innovative prescription medication products that bring more health to patients and their families. See the list of our products and full prescribing information below.
Products. Select. Cardiovascular and Metabolic Infectious Diseases Oncology Respiratory. Reset all filters.
Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products. Section Overview
Products. Click here for an overview of our human and animal health products. We provide a wide range of products to help improve the lives of humans and animals.
Boehringer Ingelheim is dedicated to providing innovative prescription medication products that bring more health to patients and their families. Aggrenox ® (aspirin/extended-release dipyridamole)
82 Boehringer Ingelheim Annual Report 2020 Bronchial asthma Bronchial asthma is a chronic inflammatory disorder of the airways. The inflammation is accompanied by airway hyper responsiveness, which leads to a narrowing of the airways and recurrent episodes of wheezing, breathlessness and coughing.
At Boehringer Ingelheim, we are providing new hope for patients by taking cancer on. Our primary focus is in lung and gastrointestinal cancers, with the goal of delivering breakthrough, first-in-class treatments that can help win the fight against cancer.
